TeleChem announces that the widely used SpotBot Personal Microarrayer now has specific application support for the Biacore Flexchip SPR analysis system.
TeleChem announces that the widely used SpotBot personal microarrayer now has specific application support for the Biacore Flexchip SPR analysis system.
Biacore, which was recently acquired by GE Healthcare, is the current market leader in SPR (surface plasmon resonance) detection platforms.
The combination of the SpotBot, 946 Micro Spotting Device, and Flexchip system empowers users to profile hundreds of proteins simultaneously in real time.
Some applications for the platform include: kinetic profiling to select for further characterization, mapping binding domains and epitopes, assessing the binding contributions of post-translational modifications such as phosphorylation, methylation or acetylation, and ranking antibody candidates for early selection.
The details of the application upgrade were worked out with experienced Biacore application specialists Michael Murphy and Brian Lang.
The programs are now available for download to all SpotBot users.
